Company Filing History:
1 out of 10 
1 out of 52 
1 out of 1,112 
Years Active: 2015-2022
Title: Jung-Ae Kim: Innovator in Pharmaceutical Chemistry
Introduction
Jung-Ae Kim is a prominent inventor based in Daegu, South Korea. With a total of four patents to her name, Kim has made significant contributions to the field of pharmaceutical chemistry. Her innovative work focuses on developing compounds that can improve treatments for various medical conditions, including osteoporosis and inflammatory bowel disease.
Latest Patents
Among her latest patents, Kim has developed a 2-cyanopyrimidin-4-yl carbamate or urea derivative, which selectively inhibits cathepsin K. This compound demonstrates great potential in preventing or treating osteoporosis. Additionally, she has introduced a pharmaceutical composition comprising this derivative, showcasing a new pathway for osteoporosis treatment.
Another remarkable patent by Kim involves a pyridinol derivative, which serves as a pharmaceutical composition for the prevention and treatment of inflammatory bowel disease. This compound exhibits an excellent colitis inhibitory effect in relevant models, indicating its potential as a novel medicinal approach for managing inflammatory bowel conditions.
Career Highlights
Throughout her career, Jung-Ae Kim has aligned herself with leading pharmaceutical enterprises. She has notably worked with Hanlim Pharmaceutical Co., Ltd. and the Research Cooperation Foundation of Yeungnam University, where her research efforts have been instrumental in advancing drug development processes.
Collaborations
Kim has collaborated with esteemed professionals in her field, including Byeong-Seon Jeong and Tae-gyu Nam. These partnerships have fostered a productive environment for innovation and have contributed significantly to her research outcomes.
Conclusion
Jung-Ae Kim’s innovative contributions to pharmaceutical chemistry illustrate her dedication to improving healthcare through science. Her patents not only highlight her inventiveness but also signify a commitment to addressing vital health challenges. As she continues her work, the impact of her inventions is expected to grow, offering new hope for patients affected by conditions like osteoporosis and inflammatory bowel disease.